3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
7
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Uterine Cervical Neoplasms
2
Polycystic Ovary Syndrome
2
Vaginal Atrophy
1
Triple Negative Breast Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcoma, Synovial
1
Rectal Neoplasms
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Metastatic Breastcancer
1
Insulin Resistance
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Endocrine System Diseases
1
Depression
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms, Male
1
Atrophic Vaginitis
1
Anxiety Disorders
1
Anus Neoplasms
1
Interventions
Metformin
149
Clomiphene
51
Letrozole
39
Inositol
35
Folic Acid
18
Exercise
17
Progesterone
15
Ethinyl Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Tablets
9
Spironolactone
9
Cholecalciferol
9
Triptorelin Pamoate
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Menotropins
7
Liraglutide
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Gonadotropins
6
Flutamide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Polycystic Ovary Syndrome
×
Dehydroepiandrosterone
×
Clear all
NCT05263557
2023-07-25
DIMOXIS
Royal College of Surgeons, Ireland
Phase NA
Unknown
20 enrolled
NCT05246865
2022-11-02
11OXO-PCOS
University of Birmingham
Phase NA
Unknown
100 enrolled